Anxiety disorders in patients with cardiopulmonary diseases: A brief review
| Autor: | J. Larry Durstine, Ashley Grace Swavely |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class Population Physical Therapy Sports Therapy and Rehabilitation Disease Anxiety Anxiolytic Quality of life (healthcare) medicine COPD Orthopedics and Sports Medicine In patient CAD education Intensive care medicine Exercise Depression (differential diagnoses) Cardiopulmonary disease education.field_of_study lcsh:R5-920 business.industry medicine.symptom business lcsh:Medicine (General) |
| Zdroj: | Sports Medicine and Health Science, Vol 2, Iss 2, Pp 72-79 (2020) |
| ISSN: | 2666-3376 |
| Popis: | This manuscript reviews the current literature involving clinical anxiety and cardiopulmonary disease, considers the hypothesized physiological mechanisms for anxiety, and discusses the use of exercise as a treatment for both anxiety and cardiopulmonary diseases. The literature summary consists of original investigations, meta-analysis, commentaries, and review publications in order to better understand the biological and psychological mechanisms for using exercise as treatment and to provide details specific to cardiopulmonary disease and anxiety management. A gap in the literature exists concerning the anxiolytic effects of exercise as a psychological and physical treatment in cardiopulmonary populations. The findings from this review support further investigation into the use of exercise to ameliorate the burden of anxiety in cardiopulmonary disease patients. This review evaluates the current literature surrounding cardiopulmonary disease and anxiety. A systematic literature search identified articles discussing the prevalence, association, and risk of anxiety in cardiopulmonary patients. Though depression is often studied in this population, recent investigation supports a need for further research regarding anxiety in cardiopulmonary patients. Treatment to manage patients’ psychological profile can reduce exacerbations of known disease, reduce hospital readmission, and improve functional capacity, and overall quality of life. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|